Ukraine ramps up cost-containment measures to “stabilise” retail drug market
The Ukrainian Government has instigated a raft of rapid cost-cutting measures across the drug retail sector, triggered by reports of…
Pricing and Market Access
Vietnam eases foreign investment restrictions in amended pharmaceutical law
Key pharma launch trends in 2024
All change in Germany – confidential pricing in, IRP out
JP Morgan 2025: Almirall updates strategy with focus on medical dermatology
Pharma to raise prices on more than 250 drugs in the US from January 2025
Setback for UK pharma as government sets unexpectedly high VPAG payback rate in 2025
Denmark’s HTA evolution
